Work

Assessment of the structural and histopathological challenges of binary electrospun PET-based nanofibers for tissue engineering applications

Year: 2025

Type: article

Abstract: Tissue engineering and regenerative medicine aim to address tissue lesions and organ degenerations, enhancing clinical outcomes by restoring damaged tissues and functionalities. Recent progress in materials science and medicine has led to the development of regenerative engineering, revolutionizing the production of polymeric artificial scaffolds by electrospinning method, which mimic the extracellular matrix (ECM). Polyurethane (PU) is recognized for its elastic nature, comprising soft and hard segments, and possesses bioactive as well as biocompatible properties. Polycaprolactone (PCL), on the other hand, is a non-toxic polymer with a viscous nature, known for its favorable mechanical properties. This study focuses on the comprehensive histological evaluation of binary electrospun PET-based nanofiber scaffolds, as widely used in tissue engineering. The structural analysis involved FE-SEM imaging, porosity measurement, FTIR, and DSC examinations. In vitro assessments included degradation rates, water uptake, cell viability, morphological cell examination, and cell attachment studies. Additionally, scaffolds were subcutaneously implanted in rats for pathological examination. After a 30 days implantation period, histological and pathological parameters such as edema, inflammation, foreign body giant cell reaction, fibrosis, necrosis, and calcification were evaluated. The results highlight the successful application of blend electrospinning in producing PET/PCL and PET/PU nanofiber scaffolds with various composition ratios. FE-SEM imaging revealed uniform nanostructures without bead formation. Histological analysis showed favorable biocompatibility, with the PET/PCL (25:75) composition demonstrating superior structural characteristics compared to other ratios. The cell studies indicated that PET-based nanofiber scaffolds exhibited suitable cell viability and attachment, underscoring their potential for tissue engineering applications. • PET/PCL/PU composite nanofibrous scaffolds show promise for TE with excellent pathological, biological, and mechanical properties. • PCL provides strength/low toxicity/slow degradation; PU offers flexibility/biocompatibility/low toxicity/slow degradation. • PET shows strong mechanical properties and biocompatibility but has limitations in its pure form. • PU degrades via ester bond hydrolysis, releasing acidic byproducts that trigger inflammation. • Fabricating biocompatible composite nanofibers mimicking ECM remains a key challenge for enhancing in vivo efficacy.

Source: Journal of Tissue Viability

DOI: 10.1016/j.jtv.2025.100888